The global biosimilar market is estimated to register a CAGR of 40.14% over the forecast period to reach a market size of US$19.151 billion by 2023 from US$2.528 billion in 2017. The increasing the revenue of the organizations towards biosimilars will increase the market during the given time period. New drug launches and collaborations have likewise helped the organizations and supported the market.